EstechPharma In Talks With German Company For MRI Contrast Medium Agents; Korean API Makers Struggle For Global Foothold
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's active pharmaceutical ingredient company EstechPharma is currently in talks with a German-based multinational company, likely Bayer Schering Pharma, to sell its two generic MRI contrast medium products